BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen CM, Chen WL, Hung CT, Lin TH, Lee MC, Chen IC, Lin CH, Chao CY, Wu YR, Chang KH, Hsieh-Li HM, Lee-Chen GJ. Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models. Aging (Albany NY) 2019;11:986-1007. [PMID: 30760647 DOI: 10.18632/aging.101804] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Phang MWL, Lew SY, Chung I, Lim WK, Lim LW, Wong KH. Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review. Chin Med 2021;16:15. [PMID: 33509239 DOI: 10.1186/s13020-020-00414-x] [Reference Citation Analysis]
2 Chung YH, Lin CW, Huang HY, Chen SL, Huang HJ, Sun YC, Lee GC, Lee-Chen GJ, Chang YC, Hsieh-Li HM. Targeting Inflammation, PHA-767491 Shows a Broad Spectrum in Protein Aggregation Diseases. J Mol Neurosci 2020;70:1140-52. [PMID: 32170713 DOI: 10.1007/s12031-020-01521-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Lee HS, Lee IH, Kang K, Park SI, Kwon TW, Lee DY. An Investigation of the Molecular Mechanisms Underlying the Analgesic Effect of Jakyak-Gamcho Decoction: A Network Pharmacology Study. Evid Based Complement Alternat Med 2020;2020:6628641. [PMID: 33343676 DOI: 10.1155/2020/6628641] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chiu YJ, Lin CH, Lee MC, Hsieh-Li HM, Chen CM, Wu YR, Chang KH, Lee-Chen GJ. Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement. Aging (Albany NY) 2021;13:15620-37. [PMID: 34106880 DOI: 10.18632/aging.203125] [Reference Citation Analysis]
5 Niewiadomska-Cimicka A, Hache A, Trottier Y. Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion. Front Neurosci 2020;14:571. [PMID: 32581696 DOI: 10.3389/fnins.2020.00571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chen CM, Chen WL, Yang ST, Lin TH, Yang SM, Lin W, Chao CY, Wu YR, Chang KH, Lee-Chen GJ. New Synthetic 3-Benzoyl-5-Hydroxy-2H-Chromen-2-One (LM-031) Inhibits Polyglutamine Aggregation and Promotes Neurite Outgrowth through Enhancement of CREB, NRF2, and Reduction of AMPKα in SCA17 Cell Models. Oxid Med Cell Longev 2020;2020:3129497. [PMID: 32377295 DOI: 10.1155/2020/3129497] [Reference Citation Analysis]
7 McIntosh CS, Li D, Wilton SD, Aung-Htut MT. Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies. Biomedicines 2021;9:1499. [PMID: 34829728 DOI: 10.3390/biomedicines9111499] [Reference Citation Analysis]
8 Chen CM, Yen CY, Chen WL, Lin CH, Wu YR, Chang KH, Lee-Chen GJ. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation. Int J Mol Sci 2021;22:1062. [PMID: 33494411 DOI: 10.3390/ijms22031062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]